Peer-reviewed veterinary case report
Thyroid hormone changes in dogs with leishmaniosis
By Saridomichelakis, Manolis N et al.·Published in Veterinary parasitology·2013·Clinic of Medicine·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
- Species:
- dog
Plain-English summary
A group of 36 dogs diagnosed with leishmaniosis (a disease caused by a parasite) were evaluated for thyroid function before and during treatment with allopurinol, sometimes combined with another medication. Before treatment, most of the dogs showed low levels of a thyroid hormone, but only a few had low levels of another thyroid hormone, and none had high levels of thyroid-stimulating hormone. During treatment, there were no significant changes in the thyroid hormone levels, but some dogs showed variations in their thyroid hormone profiles. Overall, it seems that hypothyroidism (an underactive thyroid) is not a common issue in dogs with leishmaniosis.
People also search for: dog leishmaniosis treatment · hypothyroidism in dogs symptoms · allopurinol for dog leishmaniosis
Abstract
Hypothyroidism may predispose to the development of canine leishmaniosis or it may appear during the course of the latter due to infiltration and destruction of the thyroid gland by infected macrophages. The main purpose of this study was to evaluate thyroid function through measurement of serum total thyroxin (tT₄), free thyroxin (fT₄), and canine thyroid stimulating hormone (cTSH) concentrations in 36 dogs with leishmaniosis, before and after 2 and 4 weeks of treatment with allopurinol with or without meglumine antimonate. Before treatment 27/36 (75%) dogs had serum tT₄ concentrations below the lower limit of the reference interval but only 2 of them had concurrently serum fT₄ concentrations below the lower limit of the reference interval and none had increased serum cTSH concentrations. During treatment there were no significant changes in serum tT₄ or fT₄ concentrations, whereas a significant increase in serum cTSH was observed. Two dogs had decreased serum tT₄ and fT₄ but normal cTSH concentrations before treatment and two other dogs had decreased serum tT₄ and increased cTSH, but normal fT₄ concentrations during the treatment period. Although hypothyroidism could not be definitively excluded in these dogs it is considered unlikely based on their overall hormonal profile, clinical presentation, and response to treatment. Therefore, hypothyroidism does not appear to be an important predisposing disease or a frequent complication of canine leishmaniosis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/23685064/